Abstract
A simple and green method is reported for the completely chemoselective synthesis of some new dicoumarol derivatives {3,3'-(2-aryl-2-oxoethylidene)bis[4-hydroxycoumarin]s} from the reaction of 4-hydroxycoumarin with arylglyoxals in a molar ratio of 2:1 respectively. The reactions efficiently promoted by titanium(IV) oxide nanoparticles as a heterogeneous catalyst via an on water process. Catalyst loading is very low and it shows recyclability.
Keywords: Titanium(IV) oxide nanoparticles, chemoselectivity, 3, 3'-(2-aryl-2-oxoethylidene)bis[4-hydroxycoumarin]s, catalysts, arylglyoxal.
Letters in Organic Chemistry
Title:Synthesis of New and Known Dicoumarols in Aqueous Media: A Green and Convenient Procedure Promoted by Titanium(IV) Oxide Nanoparticles
Volume: 11 Issue: 8
Author(s): Saeed Khodabakhshi, Mozhgan Shahamirian and Mojtaba Baghernejad
Affiliation:
Keywords: Titanium(IV) oxide nanoparticles, chemoselectivity, 3, 3'-(2-aryl-2-oxoethylidene)bis[4-hydroxycoumarin]s, catalysts, arylglyoxal.
Abstract: A simple and green method is reported for the completely chemoselective synthesis of some new dicoumarol derivatives {3,3'-(2-aryl-2-oxoethylidene)bis[4-hydroxycoumarin]s} from the reaction of 4-hydroxycoumarin with arylglyoxals in a molar ratio of 2:1 respectively. The reactions efficiently promoted by titanium(IV) oxide nanoparticles as a heterogeneous catalyst via an on water process. Catalyst loading is very low and it shows recyclability.
Export Options
About this article
Cite this article as:
Khodabakhshi Saeed, Shahamirian Mozhgan and Baghernejad Mojtaba, Synthesis of New and Known Dicoumarols in Aqueous Media: A Green and Convenient Procedure Promoted by Titanium(IV) Oxide Nanoparticles, Letters in Organic Chemistry 2014; 11 (8) . https://dx.doi.org/10.2174/157017861108140613162852
DOI https://dx.doi.org/10.2174/157017861108140613162852 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Detecting and Interfering Protein Interactions: Towards the Control of Biochemical Pathways
Current Medicinal Chemistry Survivin: Role in Normal Cells and in Pathological Conditions
Current Cancer Drug Targets Aptamers in Drug Design: An Emerging Weapon to Fight a Losing Battle
Current Drug Targets Passive and Active Tumour Targeting with Nanocarriers
Current Drug Discovery Technologies Sympathetic Mechanisms of Hypoglycemic Counterregulation
Current Diabetes Reviews Mitochondria in Cancer Stem Cells: A Target for Therapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery The Prediction of Human Intestinal Absorption Based on the Molecular Structure
Current Drug Metabolism Radioimmunotherapy of Cancer Using Monoclonal Antibodies to Target Radiotherapy
Current Pharmaceutical Design COX-2 Selective Inhibitors, Carbonic Anhydrase Inhibition and Anticancer Properties of Sulfonamides Belonging to This Class of Pharmacological Agents
Mini-Reviews in Medicinal Chemistry Epigenetic Modifications of the Nuclear Factor Kappa B Signalling Pathway and its Impact on Inflammatory Bowel Disease
Current Pharmaceutical Design Macrophage Derived Cystatin B/Cathepsin B in HIV Replication and Neuropathogenesis
Current HIV Research Genotoxicity of Nanocarriers
Current Drug Metabolism PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors
Current Drug Targets Leuckart Synthesis and Pharmacological Assessment of Novel Acetamide Derivatives
Anti-Cancer Agents in Medicinal Chemistry High Frequency of the Opioid Receptor µ-1 (OPRM1) A118G Polymorphism, an Opioid Drug Therapy Related Gene, in the Indonesian Population
Current Pharmacogenomics and Personalized Medicine Paving Roads for New Drugs in Oncology
Recent Patents on Anti-Cancer Drug Discovery Therapeutic Targets for Management of Periodontitis and Diabetes
Current Pharmaceutical Design Advances of Phenoxazines: Synthesis, Reactivity and Their Medicinal Applications
Current Medicinal Chemistry Bioinformatic Application in Proteomic Research on Biomarker Discovery and Drug Target Validation
Current Bioinformatics Using Small Molecule GSK3β Inhibitors to Treat Inflammation
Current Medicinal Chemistry